Contact Us
Drug Search Results
More Filters [+]

GX-G6

Alternative Names: gx-g6, gxg6, gx g6
Latest Update: 2021-07-20
Latest Update Note: News Article

Product Description

GX-G6 is long-acting GLP-1 based on Genexines proprietary hyFc Platform technology for type 2 diabetes (T2D) targeting both weekly and twice-monthly regimen compared to conventional daily therapeutics.

Mechanisms of Action: GLP-1 Agonist

Novel Mechanism: No

Modality: Peptide/Protein

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Genexine
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for GX-G6

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Type 2 Diabetes

Phase 1: General Diabetes|Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
GX-G6-002

P2

Unknown status

Type 2 Diabetes

2022-06-01

23%
GX-G6_HV1

P1

Completed

General Diabetes|Healthy Volunteers

2018-06-06

28%

Recent News Events

Date

Type

Title

07/20/2021

News Article

 Type 2 Diabetes Pipeline Holds a Potential Future in Treatment Scenario.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions